+499.5%
MRNA vs MRSH
-7.9%
+507.3%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRSH | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.4% | -0.8% | -1.7% |
| 7D | +5.5% | -3.6% | +9.1% | +6.8% |
| 30D | +158.7% | -3.0% | +161.7% | +159.4% |
| 3M | +182.1% | +15.8% | +166.3% | +178.1% |
| 6M | +151.8% | +1.6% | +150.2% | +151.7% |
| YTD | +393.6% | +1.7% | +391.8% | +390.6% |
| 1Y | +499.5% | -8.0% | +507.5% | +506.9% |
| All | +499.5% | -7.9% | +507.3% | +506.9% |
Cumulative growth
Daily Returns
Daily percentage return beside MRSH.
Daily Out/Under-Performance
Portfolio return minus MRSH return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRSH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRSH wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling